Accelera Revenue
Research Services • 
Milan, Lombardy, Italy • 51-100 Employees
Accelera revenue & valuation
| Annual revenue | $4,705,525 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $15,100,000 |
| Total funding | No funding |
Key Contacts at Accelera
Francesca Buono
Scientist Associate Junior - Study Director In Dart And Toxicology
Eva Tamborini
Study Director
Andrea Merlo
Company Owner
Claudio Bernardi
Director, Operations & Compliance
Valeria Zanoni
Bioanalyst And Study Director
Valeria Perego
Study Director
Chiara Storti
Study Director
Anna Degrassi
Toxicology Study Director
Monica Messina
Study Director
Mike Wing
Chief Executive Officer
Company overview
| Headquarters | Milan, Lombardy, Italy |
| Phone number | +3903311984444 |
| Websites | |
| NAICS | 5417 |
| Keywords | Contract Research Organization, CRO, Biosimilar, R&D, GLP, Preclinical Research, Ind Package, Non Clinical Development |
| Founded | 2008 |
| Employees | 51-100 |
| Socials |
Accelera Email Formats
Accelera uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@accelera.org), used 78.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@accelera.org | 78.4% |
{first initial}.{last name} | j.doe@accelera.org | 21.6% |
About Accelera
Accelera is one of the few Italian companies committed in preclinical research and offers integrated high level services for biotech and pharmaceutical companies, as well as academic Institutes and non-profit organizations, at a worldwide level. We have more than 15 years of experience as CRO for Clients around the world (Europe, South Korea, US, UK) supporting various TA mainly based on Client’s pipelines and new modalities (e.g. cell based therapies). We work equally with small molecules and biologics; all regularly considered test species are available (rodents and non-rodents); all major administration routes are covered. We provide the entire range from proof of concept/efficacy (oncology), preliminary non-GLP tox&safety up to the full GLP tox (including genotox and safety pharmacology), chronic and DART reprotox studies. With over 25 integrated development programs executed in the last few years, we are proud to be working with over 100 Sponsors. The reliability of results and their acceptability worldwide is guaranteed by qualified scientific teams, advanced platforms and technologies located in a wide modular structure and high quality certification by Regulatory Agencies for Good Laboratory Practices (GLP) and AAALAC. Accelera experts are involved in the development and validation of innovative and alternative methods in collaboration with most representative centers of reference and in teaching in higher education programme. Details on Accelera services and more info on expertise & capabilities on: http://www.accelera.org/ info@accelera.org
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Accelera has 24 employees across 8 departments.
Departments
Number of employees
Funding Data
Accelera has never raised funding before.
Accelera Tech Stack
Discover the technologies and tools that power Accelera's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
PaaS
Load balancers
Miscellaneous
JavaScript frameworks
Miscellaneous
Font scripts
New Zealand
United Arab Emirates
South Africa
Frequently asked questions
4.8
40,000 users
